OXiGENE Inc (OXGN.OQ)

OXGN.OQ on NASDAQ Stock Exchange Capital Market

2.88USD
1 Aug 2013
Price Change (% chg)

$0.07 (+2.49%)
Prev Close
$2.81
Open
$2.79
Day's High
$2.88
Day's Low
$2.79
Volume
300
Avg. Vol
8,596
52-wk High
$9.36
52-wk Low
$2.35

OXGN.OQ

Chart for OXGN.OQ

About

OXiGENE, Inc. (OXiGENE) is a clinical-stage, biopharmaceutical company developing therapeutics primarily to treat cancer. The Company’s primary focus is the development of product candidates referred to as vascular disrupting agents (VDAs), that disable and destroy abnormal blood vessels that provide solid tumors a means of... (more)
No analyst recommendations are available for OXGN.OQ.

Overall

Beta: 1.86
Market Cap (Mil.): $6.37
Shares Outstanding (Mil.): 2.27
Dividend: --
Yield (%): --

Financials

  OXGN.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -5.21 -- --
ROI: -135.97 -2.58 18.76
ROE: -136.03 -2.66 19.59
Search Stocks

Competitors

  Price Change
Sanofi SA (SASY.PA) €76.37 -3.80
MediciNova, Inc. (MNOV.OQ) $2.60 -0.08
Myrexis Inc (MYRX.PK) $0.07 +0.00
Novartis AG (NOVN.VX) CHF66.60 +0.35
Roche Holding Ltd. (ROG.VX) CHF228.00 -3.50
Merck & Co., Inc. (MRK.N) $48.10 -0.07

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$58.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$460.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks